• Issue

    The Prostate: Volume 83, Issue 4

    305-391
    March 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 305
  • First Published: 23 January 2023

ORIGINAL ARTICLES

Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer

Yushi Naito MD,  Masashi Kato PhD,  Hideji Kawanishi MD,  Akiyuki Yamamoto MD,  Fumitoshi Sakamoto MD,  Hiroki Hirabayashi MD,  Masataka Kobayashi MD,  Yoshihisa Matsukawa PhD,  Tohru Kimura MD,  Hidemori Araki PhD,  Toshinori Nishikimi PhD,  Atsuya Kondo MD,  Yasushi Yoshino PhD,  Yoshimasa Hashimoto MD,  Yojiro Nakano MD,  Toyonori Tsuzuki PhD, 
  • Pages: 307-315
  • First Published: 24 November 2022

Impact of American Society of Anesthesiologists score on postoperative holmium enucleation of the prostate outcomes and complications

Mary E. Soyster MD,  Deepak Agarwal MD,  Austen Slade MD,  Erica Sahm,  Tim Large MD,  Marcelino Rivera MD, 
  • Pages: 316-322
  • First Published: 22 November 2022

Prostate magnetic resonance imaging-targeted biopsy global grade correlates better than highest grade with prostatectomy grade

Joyce Ren MD,  Jonathan Melamed MD,  Samir S. Taneja MD,  James S. Wysock MD,  William C. Huang MD,  Herbert Lepor MD,  Fang-Ming Deng MD, PhD, 
  • Pages: 323-330
  • First Published: 03 December 2022

The cribriform morphology impairs Gleason 7 prostate cancer lesion detection on multiparametric magnetic resonance imaging

Ozgur Kazan MD,  Nesrin Gunduz MD,  Gozde Kir MD,  Ayberk Iplikci MD,  Mahmut B. Dogan MD,  Gozde E. Cecikoglu MD,  Meftun Culpan MD,  Asif Yildirim MD, 
  • Pages: 331-339
  • First Published: 07 December 2022

A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer

Jaroslav Juracek PhD,  Marie Madrzyk MSc,  Michal Stanik MD, PhD,  Michaela Ruckova MSc,  Karolina Trachtova MSc,  Hana Malcikova MSc,  Eva Lzicarova MD,  Dominik A. Barth MD, PhD,  Martin Pichler MD, MSc, PhD,  Ondrej Slaby PhD, 
  • Pages: 340-351
  • First Published: 08 December 2022

Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium

James Stinson MD,  Cordero McCall MBA, MPH,  Ryan W. Dobbs MD,  Neil Mistry MD,  Adrian Rosenberg BA,  Oluwarotimi S. Nettey MD,  Pooja Sharma BS, BA, BMS,  Michael Dixon BS,  Jamila Sweis BS,  Virgilia Macias MD,  Roohollah Sharifi MD,  Rick A. Kittles PhD,  Andre Kajdacsy-Balla MD, PhD,  Adam B. Murphy MD, MBA, MSCI, 
  • Pages: 352-363
  • First Published: 07 December 2022

Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells

Takeshi Sasaki MD, PhD,  Yumi Yoshikawa,  Takumi Kageyama MD,  Yusuke Sugino MD,  Manabu Kato MD, PhD,  Satoru Masui MD,  Kouhei Nishikawa MD, PhD,  Takahiro Inoue MD, PhD, 
  • Pages: 364-375
  • First Published: 07 December 2022
Open Access

A correlative biomarker study and integrative prognostic model in chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide

María P. Fernandez-Perez PhD,  Enrique Perez-Navarro BSc,  Teresa Alonso-Gordoa MD,  Vicenza Conteduca MD,  Albert Font MD,  Sergio Vázquez-Estévez MD,  Aránzazu González-del-Alba MD,  Daniel Wetterskog PhD,  Emmanuel S. Antonarakis MD,  Begona Mellado MD, PhD,  Ovidio Fernandez-Calvo MD,  María J. Méndez-Vidal MD,  Miguel A. Climent MD,  Ignacio Duran MD, PhD,  Enrique Gallardo MD,  Angel Rodriguez Sanchez MD,  Carmen Santander MD,  Maria I. Sáez MD,  Javier Puente MD, PhD,  Julian Tudela MD,  Alberto Martínez BSc,  Maria J. López-Andreo PhD,  José Padilla BSc,  Rebeca Lozano MD, PhD,  David Hervas BSc,  Jun Luo PhD,  Ugo de Giorgi MD,  Daniel Castellano MD,  Gerhardt Attard MD, PhD,  Enrique Grande MD,  Enrique Gonzalez-Billalabeitia MD, PhD, 
  • Pages: 376-384
  • First Published: 23 December 2022
Open Access

Importance of magnetic resonance imaging and prostate-specific membrane antigen PET-CT in patients treated with salvage radical prostatectomy for radiorecurrent prostate cancer

Pawel Rajwa MD, PhD,  David Pfister MD, PhD,  Constantin Rieger MD, PhD,  Julian Heidenreich MD,  Alexander Drzezga MD, PhD,  Thorsten Persigehl MD, PhD,  Shahrokh F. Shariat MD, PhD,  Axel Heidenreich MD, PhD, 
  • Pages: 385-391
  • First Published: 23 December 2022